Gemtuzumab Ozogamicin in Induction and Glasdegib in Postremission Therapy in Patients With AML (Acute Myeloid Leukemia)
Clinical trial NCT04093505 · TERMINATED
Trial details
- NCT number
- NCT04093505
- Sponsor
- University Hospital Heidelberg
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-01
- Primary completion
- 2022-06-15
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.